BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 38640338)

  • 21. Overexpression of glypican-3 is a predictor of poor prognosis in hepatocellular carcinoma: An updated meta-analysis.
    Zhang J; Zhang M; Ma H; Song X; He L; Ye X; Li X
    Medicine (Baltimore); 2018 Jun; 97(24):e11130. PubMed ID: 29901640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Prognostic Significance of NEK2 in Hepatocellular Carcinoma: Evidence from a Meta-Analysis and Retrospective Cohort Study.
    Cheng Y; Chen X; Ye L; Zhang Y; Liang J; Liu W; Zhou B; Zheng S; Huang Y; Chen G; Deng Y; Zhang Q; Yang Y
    Cell Physiol Biochem; 2018; 51(6):2746-2759. PubMed ID: 30562736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The EpCAM overexpression is associated with clinicopathological significance and prognosis in hepatocellular carcinoma patients: A systematic review and meta-analysis.
    Zhou L; Zhu Y
    Int J Surg; 2018 Aug; 56():274-280. PubMed ID: 29936198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognostic role of tumor associated macrophages in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis.
    Bisheshar SK; van der Kamp MF; de Ruiter EJ; Ruiter LN; van der Vegt B; Breimer GE; Willems SM
    Oral Oncol; 2022 Dec; 135():106227. PubMed ID: 36335818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic and clinical significance of tumor-associated macrophages in esophageal squamous cell carcinoma after surgery: do biomarkers and distributions matter?
    Yi B; Zeng J; Li L; Zhang J; Chen Y; Gao Y
    Biosci Rep; 2024 Apr; 44(4):. PubMed ID: 38501293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis.
    Yuan X; Zhang J; Li D; Mao Y; Mo F; Du W; Ma X
    Gynecol Oncol; 2017 Oct; 147(1):181-187. PubMed ID: 28698008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic outcome and related predictors of stereotactic body radiotherapy for small liver-confined HCC: a systematic review and meta-analysis of observational studies.
    Long Y; Liang Y; Li S; Guo J; Wang Y; Luo Y; Wu Y
    Radiat Oncol; 2021 Apr; 16(1):68. PubMed ID: 33832536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic and Clinical Significance of Aspartate Aminotransferase-to-Lymphocyte Ratio Index in Individuals with Liver Cancer: A Meta-Analysis.
    Peng X; Huang Y; Zhang M; Chen Y; Zhang L; He A; Luo R
    Dis Markers; 2022; 2022():3533714. PubMed ID: 35186165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Value of Lactate Dehydrogenase in Patients with Hepatocellular Carcinoma: A Meta-Analysis.
    Kong W; Zuo X; Liang H; Hu J; Zhang H; Wang X; Chen W
    Biomed Res Int; 2018; 2018():1723184. PubMed ID: 30687735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic and clinicopathological significance of glypican-3 overexpression in hepatocellular carcinoma: a meta-analysis.
    Li J; Gao JZ; Du JL; Wei LX
    World J Gastroenterol; 2014 May; 20(20):6336-44. PubMed ID: 24876756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic resection alone versus in combination with pre- and post-operative transarterial chemoembolization for the treatment of hepatocellular carcinoma: A systematic review and meta-analysis.
    Qi X; Liu L; Wang D; Li H; Su C; Guo X
    Oncotarget; 2015 Nov; 6(34):36838-59. PubMed ID: 26451613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver transplantation vs liver resection in patients with HBV-related hepatocellular carcinoma beyond Milan criterion: A meta-analysis.
    Li W; Li L; Han J; Wu H
    Clin Transplant; 2018 Mar; 32(3):e13193. PubMed ID: 29315813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of HIF-1α expression in hepatocellular carcinoma: a meta-analysis.
    Zheng SS; Chen XH; Yin X; Zhang BH
    PLoS One; 2013; 8(6):e65753. PubMed ID: 23799043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.
    Fan QM; Jing YY; Yu GF; Kou XR; Ye F; Gao L; Li R; Zhao QD; Yang Y; Lu ZH; Wei LX
    Cancer Lett; 2014 Oct; 352(2):160-8. PubMed ID: 24892648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meta-analysis of the prognostic and clinical value of tumor-associated macrophages in adult classical Hodgkin lymphoma.
    Guo B; Cen H; Tan X; Ke Q
    BMC Med; 2016 Oct; 14(1):159. PubMed ID: 27745550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prognostic value of tumour-associated macrophages in Non-Hodgkin's lymphoma: A systematic review and meta-analysis.
    Xu X; Li Z; Liu J; Zhu F; Wang Z; Wang J; Zhang J; Wang H; Zhai Z
    Scand J Immunol; 2020 Jan; 91(1):e12814. PubMed ID: 31419843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathological and prognostic significance of high Ki-67 labeling index in hepatocellular carcinoma patients: a meta-analysis.
    Luo Y; Ren F; Liu Y; Shi Z; Tan Z; Xiong H; Dang Y; Chen G
    Int J Clin Exp Med; 2015; 8(7):10235-47. PubMed ID: 26379815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Significance of Pretreatment Apolipoprotein A-I as a Noninvasive Biomarker in Cancer Survivors: A Meta-Analysis.
    Zhang Y; Yang X
    Dis Markers; 2018; 2018():1034037. PubMed ID: 30510601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does postoperative adjuvant transarterial chemoembolization benefit for all patients with hepatocellular carcinoma combined with microvascular invasion: a meta-analysis.
    Wang L; Ke Q; Lin N; Zeng Y; Liu J
    Scand J Gastroenterol; 2019 May; 54(5):528-537. PubMed ID: 31081401
    [No Abstract]   [Full Text] [Related]  

  • 40. Prognostic utility of systemic inflammatory markers and chronic hepatitis C virus infection status in hepatocellular carcinoma patients treated with local ablation.
    Ali MAM; Harmsen WS; Morsy KH; Galal GMK; Therneau TM; Roberts LR
    BMC Cancer; 2022 Feb; 22(1):221. PubMed ID: 35227234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.